TipRanks
Indo Amines Limited (IN:INDOAMIN)
:INDOAMIN
India Market
Want to see IN:INDOAMIN full AI Analyst Report?

Indo Amines Limited (INDOAMIN) AI Stock Analysis

1 Followers

Top Page

IN:INDOAMIN

Indo Amines Limited

(INDOAMIN)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - Gpt-5.6Sol)
Rating:61Neutral
Price Target:
₹134.00
▲(4.08% Upside)
Action:Reiterated
Date:09/20/26
The score is driven primarily by improving profitability and healthy ROE, but is held back by weak cash conversion and negative free cash flow in the last two years. Valuation is supportive with a relatively low P/E, while technical indicators are neutral-to-slightly cautious due to a negative MACD and only modest trend strength.
Positive Factors
Steady Revenue Growth
Steady revenue expansion indicates continued demand across the company’s industrial chemical markets and provides a foundation for future operating leverage. The FY2026 acceleration is particularly supportive because sustained top-line growth can help broaden customer reach and improve earnings capacity over the next several quarters.
Negative Factors
Persistent Negative Free Cash Flow
Two consecutive years of negative free cash flow show that reported earnings have not consistently translated into surplus cash after investment needs. This can constrain internally funded expansion and may increase reliance on financing or working-capital improvement, making cash generation a durable execution issue.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady Revenue Growth
Steady revenue expansion indicates continued demand across the company’s industrial chemical markets and provides a foundation for future operating leverage. The FY2026 acceleration is particularly supportive because sustained top-line growth can help broaden customer reach and improve earnings capacity over the next several quarters.
Read all positive factors

Indo Amines Limited (INDOAMIN) vs. iShares MSCI India ETF (INDA)

Indo Amines Limited Business Overview & Revenue Model

Company Description
Indo Amines Limited operates as a global manufacturer and supplier, focusing on the development and production of a comprehensive range of chemicals, including fine, specialty, performance, and perfumery chemicals, alongside active pharmaceutical ...
How the Company Makes Money
Indo Amines Limited makes money mainly by manufacturing and selling amines and amine-based specialty/intermediate chemicals to other businesses. Revenue is generated through (1) sale of manufactured chemical products: the company produces amines a...

Indo Amines Limited Financial Statement Overview

Summary
Profitability and returns have improved (FY2026 net margin ~6.8%, operating margin ~8.7%, ROE ~20.2%) and leverage is moderate with a better debt-to-equity trend (~0.79 in FY2026). However, cash conversion is the key weakness: free cash flow has been negative in FY2025 and FY2026 (about -0.22B each year) and operating cash flow is uneven, reducing financial flexibility.
Income Statement
74
Positive
Balance Sheet
66
Positive
Cash Flow
42
Neutral
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue11.60B10.79B9.40B9.41B7.79B
Gross Profit3.04B2.75B2.20B2.30B1.91B
EBITDA1.23B1.16B936.55M913.41M604.51M
Net Income793.26M558.95M428.13M408.75M230.47M
Balance Sheet
Total Assets8.97B7.79B6.33B5.97B5.54B
Cash, Cash Equivalents and Short-Term Investments237.05M167.79M55.89M60.73M61.66M
Total Debt3.11B2.84B2.17B2.32B2.07B
Total Liabilities5.04B4.61B3.70B3.71B3.67B
Stockholders Equity3.92B3.17B2.63B2.25B1.87B
Cash Flow
Free Cash Flow-220.64M-216.82M391.02M-109.75M-242.71M
Operating Cash Flow563.71M697.01M696.71M203.63M154.59M
Investing Cash Flow-718.75M-904.58M-265.64M-298.27M-388.40M
Financing Cash Flow225.81M153.96M-408.70M40.26M319.15M

Indo Amines Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price128.75
Price Trends
50DMA
125.78
Positive
100DMA
127.03
Negative
200DMA
119.62
Positive
Market Momentum
MACD
-0.17
Negative
RSI
53.79
Neutral
STOCH
49.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDOAMIN, the sentiment is Positive. The current price of 128.75 is above the 20-day moving average (MA) of 123.67, above the 50-day MA of 125.78, and above the 200-day MA of 119.62, indicating a bullish trend. The MACD of -0.17 indicates Negative momentum. The RSI at 53.79 is Neutral, neither overbought nor oversold. The STOCH value of 49.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:INDOAMIN.

Indo Amines Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
₹9.38B24.470.30%-12.40%-3.04%
64
Neutral
₹17.70B5.340.98%12.01%23.71%
63
Neutral
₹5.18B32.52-2.70%-15.41%
61
Neutral
₹9.21B11.400.39%13.23%22.22%
59
Neutral
₹7.00B17.510.88%49.58%43.22%
57
Neutral
₹11.82B22.120.99%1.41%946.41%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:INDOAMIN
Indo Amines Limited
126.85
-16.57
-11.55%
IN:AMNPLST
Amines & Plasticizers Ltd.
170.40
-56.27
-24.82%
IN:DMCC
DMCC Speciality Chemicals Limited
280.50
-29.77
-9.59%
IN:INDIAGLYCO
India Glycols Limited
264.00
85.35
47.78%
IN:PRIMO
Primo Chemicals Limited
21.36
-4.64
-17.85%
IN:VALIANTORG
Valiant Organics Limited
421.60
63.85
17.85%

Indo Amines Limited Corporate Events

Indo Amines halts Mahad plant after fatal gas leak incident
Aug 17, 2026
Indo Amines Limited has reported a gas leakage incident at its Mahad manufacturing facility in Raigad, Maharashtra, on 15 August 2026, which resulted in the death of one company worker and a person from a neighbouring industrial unit, while others...
Indo Amines strengthens board with appointment of legal expert as Independent Director
Jul 11, 2026
Indo Amines Limited has appointed legal veteran Rahul Chitnis as an Additional Independent Director for a one-year term starting July 15, 2026, subject to shareholder approval. The board’s decision, based on the Nomination and Remuneration C...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 20, 2026